TABLE 3

Respiratory Support Modality and Associated Clinical and Demographic Data

	Nonintubated			Intubated
	NC/NRB	NPPV		IMV-OSH	IMV-PCH
	NC/NRB	HFNC	CPAP/BiPAP	IMV-OSH	IMV-PCH
Total, n (%)	184 (70)	26 (10)	37 (14)	11 (4)	4 (2)
Age, y, median (range)	6 (2–17)	6 (2–14)	9 (2–15)^a	6 (2–13)	4 (3–7)
PICU LOS, d, median (range)	1.2 (0.2–11.4)	3.6 (0.6–8.5)^a	3.6 (1.0–9.0)^a	2.6 (0.4–4.5)	12.7 (10.9–14.8)^b
PICU LOS <24 h, n (%)	62 (34)	2 (8)	0	2 (18)	0
PICU LOS 1–3 d, n (%)	97 (53)	8 (31)	14 (38)	5 (45)	0
PICU LOS >3 d, n (%)	25 (14)	16 (62)	23 (62)	4 (36)	4 (100)
CXR and/or admission, median (range)	1.0 (0–1.0)	2.0 (1.0–4.0)^a	1.0 (1.0–4.0)	3.0 (1.0–5.0)	15 (11.3–18.0)^b
Laboratories and/or admission, median (range)
Blood gas panel	1.0 (0–1.0)	1.5 (1.0–3.3)^a	2.0 (1.0–4.0)^a	4.0 (2.0–13.0)	27.0 (5.3–40.4)
CBC	0 (0–0)	1 (0–1.0)^a	1.0 (0–1.0)^a	1 (0–3.0)	2.5 (1.0–10.8)
Chemistry panel	1.0 (0–1.0)	1.5 (1.0–3.0)^a	1.0 (1.0–2.0)^a	2.0 (1.0–9.0)	13 (10.0–22.0)^b

↵^a Comparison groups include only those who never received invasive ventilation; P < .0125 for pairwise comparisons with the NC/NRB group.
↵^b Comparisons are among only those receiving invasive mechanical ventilation.